Acadian Asset Management’s Epizyme, Inc EPZM Stock Holding History

Acadian Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-805,798	Closed	-$1.18M	–	1932
2022 Q2	$1.18M	Buy	805,798 +511,127	+173%	+$376K	0.01%	778
2022 Q1	$337K	Buy	+294,671	New	+$480K	﹤0.01%	1091

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Acadian Asset Management's EPZM Position: Q3 2022 in Review

Acadian Asset Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 805,798 shares — an estimated $1.18M sold.

Acadian Asset Management first reported a position in EPZM in Q1 2022 and held it in 2 quarters. The position peaked at $1.18M in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Acadian Asset Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Acadian Asset Management sold 805,798 Epizyme, Inc shares in Q3 2022, an estimated $1.18M.
Acadian Asset Management first reported a position in Epizyme, Inc in Q1 2022 and held it in 2 quarters.
Acadian Asset Management's Epizyme, Inc position peaked at $1.18M in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Acadian Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.